This increase may warrant attention — for this metric, lower values are generally preferred.
An increase signals that past acquisitions are underperforming or that market conditions have deteriorated, negatively impacting shareholder value.
This represents a non-cash charge taken when the carrying value of an acquired asset exceeds its fair market value. It i...
Standard accounting metric for companies that grow through M&A.
goodwill_impairment| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $229.70M | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | -100.0% | — |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|
| Precision and Science Technologies | $57.43M | $57.43M | $57.43M | $57.43M |
| Aerospace & Defense | — | $59.40M | — | — |
| Biopharma | — | $170.30M | — | — |
| Industrial Technologies and Services | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $0.00 | $229.70M | $0.00 | $0.00 |
Industrial Technologies and Services, Precision and Science Technologies are derived from annual filings.
Aerospace & Defense, Biopharma, Industrial Technologies and Services, Precision and Science Technologies were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.